Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
EUDA Health Holdings Limited(EUDA)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for EUDA
11/03/2026: EUDA (1-star) is currently NOT-A-BUY. Pass it for now.
EUDA Health Holdings Limited is a growth-stage health technology company operating a digital platform that connects patients, healthcare providers, and insurers across Southeast Asia. Its primary strength lies in its AI-powered ecosystem, which aims to reduce friction in the healthcare experience. The core investment story centers on the digital transformation of regional healthcare, offering significant growth potential if the company can scale its partner network effectively. Risks are elevated due to intense competition from well-capitalized apps, regulatory complexities, and the need to achieve sustainable cash flow. This stock may suit growth-oriented investors, though they should monitor regional adoption and strategic partnership progress.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The company offers exposure to the nascent Southeast Asian health-tech market but remains in early development. |
| Momentum investor | Weak fit | The stock lacks consistent, strong upward price momentum required for a typical momentum strategy. |
| Value investor | Weak fit | The company does not yet possess the stable earnings or assets typically required for value-based selection. |
| Dividend investor | Weak fit | EUDA does not pay a dividend and focuses on cash deployment for business expansion. |
| Low-risk investor | Weak fit | The volatility and operational risks associated with a small-cap, growth-stage health-tech firm are unsuitable. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock price is subject to significant swings typical of small-cap growth entities. |
| Valuation risk | Medium / high | Valuations for early-stage tech companies can be sensitive to interest rates and growth projections. |
| Competition risk (Digital health app competition) | High | The sector is crowded with well-funded competitors attempting to capture the same user base. |
| Business quality | Medium | The business model is unproven at scale relative to industry giants. |
| Dividend income | Low / none | Investors should expect zero income from dividends in the near term. |
| Execution risk | Medium / high | Successfully scaling across disparate Southeast Asian regulatory environments remains a primary hurdle. |
Price Behavior
Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.
Extreme Price Shocks
The stock has experienced exceptionally large and disruptive price movements during the period.
Analysis of Past Performance
Type Stock | Historic Profit -37.18% | Avg. Invested days 21 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 11/03/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 47.64M USD | Price to earnings Ratio - | 1Y Target Price 55 |
Price to earnings Ratio - | 1Y Target Price 55 | ||
Volume (30-day avg) 40.9K shares | Beta 0.55 | 52 Weeks Range 5.26 - 71.20 | Updated Date 11/03/2026 |
52 Weeks Range 5.26 - 71.20 | Updated Date 11/03/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.16 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Digital Platform Services | Subscription and transaction fees from patients and providers using the mobile application. | Revenue is generated by providing a digital marketplace that connects healthcare participants. |
| Enterprise Solutions | Software-as-a-Service fees from insurance partners for claims and network management. | The company sells software tools that help insurers manage healthcare data more efficiently. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE - | Forward PE 7.81 | Enterprise Value 47.01M | Price to Sales(TTM) 6.59 |
Enterprise Value 47.01M | Price to Sales(TTM) 6.59 | ||
Enterprise Value to Revenue 6.5 | Enterprise Value to EBITDA -25.9 | Shares Outstanding 2.99M | Shares Floating 1.76M |
Shares Outstanding 2.99M | Shares Floating 1.76M | ||
Percent Insiders 41.17 | Percent Institutions - |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.